Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $24.8900 (3.24%) ($24.2700 - $25.3500) on Thu. Oct. 12, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.87% (three month average) | RSI | 58 | Latest Price | $24.8900(3.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.1% a day on average for past five trading days. | Weekly Trend | EDIT advances 7% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(63%) IBB(63%) XBI(61%) IWO(58%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -2.435% in a week (0% probabilities). VIXM(-13%) TLT(-6%) SHY(-5%) UUP(-4%) GDXJ(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.435% (StdDev 4.87%) | Hourly BBV | 0 () | Intraday Trend | 2.6% | | | |
|
5 Day Moving Average | $24.85(0.16%) | 10 Day Moving Average | $24.69(0.81%) | 20 Day Moving Average | $23.29(6.87%) | To recent high | -2.5% | To recent low | 61.1% | Market Cap | $1.546b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |